Cargando…

Characterization of human FCRL4-positive B cells

FCRL4 is an immunoregulatory receptor that belongs to the Fc receptor-like (FCRL) family. In healthy individuals, FCRL4 is specifically expressed by memory B cells (MBCs) localized in sub-epithelial regions of lymphoid tissues. Expansion of FCRL4(+) B cells has been observed in blood and other tissu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jourdan, Michel, Robert, Nicolas, Cren, Maïlys, Thibaut, Coraline, Duperray, Christophe, Kassambara, Alboukadel, Cogné, Michel, Tarte, Karin, Klein, Bernard, Moreaux, Jérôme
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479562/ https://www.ncbi.nlm.nih.gov/pubmed/28636654 http://dx.doi.org/10.1371/journal.pone.0179793

Ejemplares similares

RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulators
por: Kassambara, Alboukadel, et al.
Publicado: (2021)

GenomicScape: An Easy-to-Use Web Tool for Gene Expression Data Analysis. Application to Investigate the Molecular Events in the Differentiation of B Cells into Plasma Cells
por: Kassambara, Alboukadel, et al.
Publicado: (2015)

Differential effects of lenalidomide during plasma cell differentiation
por: Jourdan, Michel, et al.
Publicado: (2016)

Global miRNA expression analysis identifies novel key regulators of plasma cell differentiation and malignant plasma cell
por: Kassambara, Alboukadel, et al.
Publicado: (2017)

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistance
por: Vikova, Veronika, et al.
Publicado: (2019)

RECQ helicases are deregulated in hematological malignancies in association with a prognostic value
por: Viziteu, Elena, et al.
Publicado: (2016)

Phenotypic Characterization of Diffuse Large B-Cell Lymphoma Cells and Prognostic Impact
por: Devin, Julie, et al.
Publicado: (2019)

Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma
por: Kassambara, Alboukadel, et al.
Publicado: (2012)

Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells
por: Kassambara, Alboukadel, et al.
Publicado: (2013)

An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy
por: Szablewski, Vanessa, et al.
Publicado: (2018)

Drug metabolism and clearance system in tumor cells of patients with multiple myeloma
por: Hassen, Wafa, et al.
Publicado: (2014)

Kinome expression profiling to target new therapeutic avenues in multiple myeloma
por: de Boussac, Hugues, et al.
Publicado: (2020)

A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy
por: Kassambara, Alboukadel, et al.
Publicado: (2014)

In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma
por: Maes, Ken, et al.
Publicado: (2014)

FCRL1 immunoregulation in B cell development and malignancy
por: Mamidi, Murali K., et al.
Publicado: (2023)

RNA-Sequencing-Based Transcriptomic Score with Prognostic and Theranostic Values in Multiple Myeloma
por: Alaterre, Elina, et al.
Publicado: (2021)

Roles for the FCRL6 Immunoreceptor in Tumor Immunology
por: Davis, Randall S.
Publicado: (2020)

PRC2 targeting is a therapeutic strategy for EZ score defined high-risk multiple myeloma patients and overcome resistance to IMiDs
por: Herviou, Laurie, et al.
Publicado: (2018)

FCRL5(+) Memory B Cells Exhibit Robust Recall Responses
por: Kim, Charles C., et al.
Publicado: (2019)

Upregulated Fcrl5 disrupts B cell anergy causes autoimmune disease
por: Ono, Chisato, et al.
Publicado: (2023)

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells
por: Bruyer, Angelique, et al.
Publicado: (2018)

EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation
por: Herviou, Laurie, et al.
Publicado: (2019)

Transcription/Replication Conflicts in Tumorigenesis and Their Potential Role as Novel Therapeutic Targets in Multiple Myeloma
por: Dutrieux, Laure, et al.
Publicado: (2021)

Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells
por: Lub, Susanne, et al.
Publicado: (2015)

Single Nucleotide Polymorphisms of FCRL3 in Iranian Patients with Behcet’s Disease
por: SHAHRAM, Farhad, et al.
Publicado: (2019)

Evidence for Extensive Duplication and Subfunctionalization of FCRL6 in Armadillo (Dasypus novemcinctus)
por: Matos, Maria Carolina, et al.
Publicado: (2023)

The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model
por: Amin, Rada, et al.
Publicado: (2014)

Growth factors in multiple myeloma: a comprehensive analysis of their expression in tumor cells and bone marrow environment using Affymetrix microarrays
por: Mahtouk, Karène, et al.
Publicado: (2010)

The hydroxymethylome of multiple myeloma identifies FAM72D as a 1q21 marker linked to proliferation
por: Chatonnet, Fabrice, et al.
Publicado: (2020)

FCRL5 Delineates Functionally Impaired Memory B Cells Associated with Plasmodium falciparum Exposure
por: Sullivan, Richard T., et al.
Publicado: (2015)

The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology
por: Liang, Xiao, et al.
Publicado: (2023)

Gene expression-based risk score in diffuse large B-cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2012)

Nucleotide excision DNA repair pathway as a therapeutic target in patients with high-risk diffuse large B cell lymphoma
por: Bret, Caroline, et al.
Publicado: (2013)

B cell overexpression of FCRL5 and PD-1 is associated with low antibody titers in HCV infection
por: Ogega, Clinton O., et al.
Publicado: (2022)

Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity?
por: Eyre, Stephen, et al.
Publicado: (2006)

Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome
por: Li, Ke, et al.
Publicado: (2009)

Pooled genome wide association detects association upstream of FCRL3 with Graves’ disease
por: Khong, Jwu Jin, et al.
Publicado: (2016)

HBV induces inhibitory FcRL receptor on B cells and dysregulates B cell-T follicular helper cell axis
por: Poonia, Bhawna, et al.
Publicado: (2018)

Correction: Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity?
por: Eyre, Stephen, et al.
Publicado: (2008)

The FCRL3 −169T>C polymorphism and the risk of endometriosis-related infertility in a Polish population
por: Szczepańska, Malgorzata, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_20lgta9tv5c2cv411qqmb9qe3m